Former MSD head of R&D Roger Perlmutter has continued the swift development track for cancer start-up Eikon Therapeutics, filing an IPO to build its already healthy cash position further. Eikon has ...

-Price (T.Rowe) U.S. Small-Cap Value Equity Trust 466.01k Mar 31, 2026 0.86% 5,335,825 T. Rowe Price Health Sciences Fund, Inc. 349.1k Mar 31, 2026 0.64% 3,997,172 ...

Doug Wintemute is a staff writer for Forbes Advisor. After completing his master’s in English at York University, he began his writing career in the higher education space. Over the past decade, Doug ...

The Chart of the Week showcases a valuable metric: greenhouse gas emission intensities. The data reveals significant reductions in emission intensities within agricultural and industrial sectors.

Generate Biomedicines shares fall in weak Nasdaq debut for drug developer Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a ...

Tech stocks boosted Wall Street as investors prepared to close the book on a month of losses for the S&P 500 and the Nasdaq, but the strongest quarterly percentage gains for all three major U.S. stock ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...